
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy
Author(s) -
Hyeon Man Baek,
Jeon Hor Chen,
Ke Nie,
Hua Yu,
Shadfar Bahri,
Rita S. Mehta,
Orhan Nalcioǧlu,
MinYing Su
Publication year - 2009
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2512080553
Subject(s) - medicine , breast cancer , receiver operating characteristic , taxane , cyclophosphamide , regimen , mann–whitney u test , area under the curve , chemotherapy , neoadjuvant therapy , cancer , nuclear medicine , oncology
To compare changes in the concentration of choline-containing compounds (tCho) and in tumor size at follow-up after neoadjuvant chemotherapy (NAC) between patients who achieved pathologic complete response (pCR) and those who did not (non-pCR).